Parkinson's UK is a Parkinson's research and support charity in the United Kingdom. In April 2010, the Parkinson's Disease Society changed its name to become Parkinson's UK. Its aims are to improve the quality of life for people affected by Parkinson's and find a cure for the condition. Parkinson's UK is the largest charity funder of research into Parkinson's in the UK. It funds research aimed at finding better treatments and improving the understanding of Parkinson's and its causes. It raises money through donations, legacies, community fundraising, events and corporate partnerships. The charity offers support and information to people affected by Parkinson's, their families and carers through a network of 350 local groups across England, Wales, Scotland and Northern Ireland. History The Parkinson's Disease Society (Parkinson's UK) was formed in February 1969 by Mali Jenkins (4 July 1907 – 11 March 1989). Initially the organisation had 3 simple aims: to help patients and their relatives with the problems arising from Parkinson's to collect and disseminate information on Parkinson's to encourage and provide funds for research into Parkinson's Parkinson's UK now focuses on research in addition to support. The charity has also expanded to improve services for people affected by Parkinson's through education and training for professionals and campaigning. President Jane Asher has been President of Parkinson's UK since 2007 and has a brother-in-law diagnosed with Parkinson's. Asher has been involved in launching campaigns to improve research into Parkinson's. Research Parkinson's UK is the largest charitable funder of Parkinson's research in the UK and have so far invested more than £50million in research. The charity aims to 'find a cure and improve life for everyone affected by Parkinson's'. In 2009 the charity produced 'Four decades of discovery' – a booklet describing the key research achievements of the charity since 1969 which included the development of new drugs, an improved understanding of Parkinson's, and better diagnosis and care for people with the condition. In 2010 the charity spent £4.6 million on new Parkinson's research projects and launched a new 5-year research strategy called 'Our plan to cure Parkinson's'. The new strategy focuses on four central challenges: Understanding why nerve cells die in Parkinson's Developing new animal models of Parkinson's Faster, better drug screening Finding 'biomarkers' for earlier diagnosis These priorities reflect the charity's focus on basic laboratory research to understand what causes Parkinson's, how it develops, and translational research to develop new